Efficacy and Safety of Humira® in Patients With Psoriatic Arthritis in Normal Medical Practice

NCT01111240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4635

Last updated 2014-12-30

Study results available
· View outcomes & findings →

Summary

This study is a documentation of effectiveness and safety of Humira in patients with psoriatic arthritis.

Conditions

Sponsors & Collaborators

  • AbbVie (prior sponsor, Abbott)

    lead INDUSTRY

Principal Investigators

  • Bianca Wittig, MD · Abbvie Deutschland GmbH & Co. KG, Medical Department

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01111240 on ClinicalTrials.gov